Bio Research and development A/S
CVR number: 38456229
Roholmsvej 10 N, 2620 Albertslund
nln@biogroup.dk
tel: 42718228
www.biogroup.dk
Income statement (kDKK)
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 84.98 | 197.68 | - 378.90 | 3 189.35 | - 795.14 |
Employee benefit expenses | -49.23 | - 115.90 | - 137.34 | - 909.69 | -1 067.07 |
Total depreciation | -2.52 | -7.57 | -8.35 | -33.43 | -52.25 |
EBIT | 33.22 | 74.20 | - 524.59 | 2 246.23 | -1 914.45 |
Other financial income | 0.47 | 0.61 | 41.22 | 6.92 | 2.89 |
Other financial expenses | -1.23 | -16.72 | -15.49 | -47.38 | -34.81 |
Reduction non-current investment assets | -15.37 | ||||
Pre-tax profit | 32.47 | 58.09 | - 514.23 | 2 205.78 | -1 946.37 |
Income taxes | -5.32 | -22.64 | 3.44 | - 380.05 | 13.81 |
Net earnings | 27.14 | 35.45 | - 510.79 | 1 825.73 | -1 932.56 |
Assets (kDKK)
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 23.19 | 15.62 | 20.03 | 277.92 | 225.67 |
Tangible assets total | 23.19 | 15.62 | 20.03 | 277.92 | 225.67 |
Other receivables | 10.76 | 10.82 | 10.82 | 157.00 | 161.71 |
Investments total | 10.76 | 10.82 | 10.82 | 157.00 | 161.71 |
Long term receivables total | |||||
Raw materials and consumables | 203.84 | 287.66 | 65.91 | 1 164.43 | 199.28 |
Finished products/goods | 22.09 | 480.31 | 365.75 | ||
Inventories total | 203.84 | 287.66 | 88.00 | 1 644.74 | 565.03 |
Current trade debtors | 61.23 | 48.40 | 115.74 | 745.24 | 145.28 |
Prepayments and accrued income | 25.00 | 12.11 | |||
Current other receivables | 16.01 | 75.40 | 5.20 | 194.74 | |
Short term receivables total | 77.24 | 123.79 | 120.94 | 964.98 | 157.39 |
Cash and bank deposits | 34.22 | 0.25 | 13.51 | 50.40 | 0.06 |
Cash and cash equivalents | 34.22 | 0.25 | 13.51 | 50.40 | 0.06 |
Balance sheet total (assets) | 349.25 | 438.15 | 253.30 | 3 095.03 | 1 109.86 |
Equity and liabilities (kDKK)
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Share capital | 0.00 | 0.00 | 0.00 | 40.00 | 400.00 |
Shares repurchased | 300.00 | ||||
Other reserves | 27.14 | ||||
Retained earnings | -27.14 | 27.14 | 62.59 | - 788.20 | 677.53 |
Profit of the financial year | 27.14 | 35.45 | - 510.79 | 1 825.73 | -1 932.56 |
Shareholders equity total | 27.15 | 62.59 | - 448.20 | 1 377.53 | - 855.03 |
Provisions | 3.44 | 13.81 | |||
Non-current other liabilities | 768.66 | ||||
Non-current liabilities total | 768.66 | ||||
Current loans from credit institutions | 17.50 | 0.04 | |||
Current trade creditors | 92.04 | 239.30 | 152.04 | 86.59 | |
Current owed to participating | 183.86 | 121.34 | 242.98 | 188.39 | 101.67 |
Short-term deferred tax liabilities | 5.32 | 25.07 | 366.23 | ||
Other non-interest bearing current liabilities | 40.89 | 208.21 | 219.22 | 228.35 | 1 776.58 |
Current liabilities total | 322.10 | 372.12 | 701.50 | 935.02 | 1 964.88 |
Balance sheet total (liabilities) | 349.25 | 438.15 | 253.30 | 3 095.03 | 1 109.86 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.